Clinical Trials
105
Active:0
Completed:72
Trial Phases
5 Phases
Early Phase 1:2
Phase 1:7
Phase 2:14
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (64 trials with phase data)• Click on a phase to view related trials
Not Applicable
21 (32.8%)Phase 3
20 (31.3%)Phase 2
14 (21.9%)Phase 1
7 (10.9%)Early Phase 1
2 (3.1%)Impact of Therapeutic Education for Type 2 Diabetic Patients During Ramadan.
Not Applicable
Completed
- Conditions
- Diabete Mellitus
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 85
- Registration Number
- NCT07112625
- Locations
- 🇹🇳
Fattouma Bourguiba University Hospital, Monastir, Tunisia
Estimated Plasma Volume in Patients With Acute Heart Failure
Completed
- Conditions
- Acute Heart Failure
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 2500
- Registration Number
- NCT07085793
- Locations
- 🇹🇳
Emergency Department, Monastir, Tunisia
Early Recurrence of Renal Colic: Predictive Factors
Completed
- Conditions
- Renal ColicEmergency Department Patient
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 878
- Registration Number
- NCT06982430
- Locations
- 🇹🇳
Nouira Semir, Monastir, Tunisia
Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED
Phase 3
Not yet recruiting
- Conditions
- Renal Colic
- Interventions
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 300
- Registration Number
- NCT06980727
Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial
Phase 3
- Conditions
- Fluid TherapyFluid ReponsivenessFluid Resuscitation
- Interventions
- Drug: GelafundinDrug: Saline (NaCl 0,9 %) (placebo)
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 16
- Registration Number
- NCT06900972
- Locations
- 🇹🇳
Fattouma Bourguiba Hospital, MOnastir, Tunisia
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
News
No news found